Present and future treatment of peptic ulcer and potential role of DE-NOL.
D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001729:Bismuth / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004381:Duodenal Ulcer / Q000188:drug therapy; D006471:Gastrointestinal Hemorrhage / Q000150:complications; D006801:Humans; D009942:Organometallic Compounds; D010437:Peptic Ulcer / Q000188:drug therapy*; D012008:Recurrence; D013276:Stomach Ulcer / Q000188:drug therapy
D000863:Antacids; D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; C002791:bismuth tripotassium dicitrate; D001729:Bismuth